This paper describes the first potent and selective p300 histone acetyltransferase (HAT) inhibitor which is effective in live cells. This compound 7 is a coenzyme A analogue conjugated to a cell permeabilizing oligoArg peptide via disulfide linkage. This compound was shown to block cellular histone acetylation and transcription using a p300-sensitive reporter. It should thus be broadly useful for dissecting the role of p300 HAT activity in physiologic and disease states.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ja0558544 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!